Immune thrombocytopenia (ITP) is a rare condition. Its epidemiology is not well-known. First-line treatment is based on corticosteroids. ITP leads to persistency (lasting more than 3 months) in 70% of adult cases. Then, several second-line treatments (SLTs) are available, mainly splenectomy, rituximab (off-label) and thrombopoietin-receptor agonists. Their efficacy and safety have not been compared, particularly in the long-term. FAITH (French Adult primary Immune Thrombocytopenia: a pHarmacoepidemiological study) is dedicated to the building and follow-up of the cohort of all adults with primary ITP in France persistently treated (>3 months) through the database of Frenc...
Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or t...
Fei Song,1,2 Hanny Al-Samkari2,3 1Department of Medicine, Massachusetts General Hospital, Boston, MA...
This thesis consists of studies aiming to answer questions regarding the pathophysiology (ie. the ro...
Immune thrombocytopenia (ITP) is a rare condition. Its epidemiology is not well-known. Fir...
La thrombopénie immunologique (TI) est une maladie auto-immune rare. Son épidémiologie est mal connu...
The natural history and its modulation by treatments administered for immune thrombocytopenia (ITP) ...
Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated ...
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated t...
The rarity of severe complications of this disease in children makes randomized clinical trials in i...
This thesis investigates immune-mediated thrombocytopenia: the natural history of immune thrombocyto...
5siIntroduction: Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a ...
Immune thrombocytopenia (ITP) is an acquired disorder characterized by isolated thrombocytopenia wit...
Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and ...
peer reviewedThe Belgian Hematology Society (BHS) updated the 2013 guidelines for diagnosis and trea...
peer reviewedThe Belgian Hematology Society (BHS) updated the 2013 guidelines for diagnosis and trea...
Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or t...
Fei Song,1,2 Hanny Al-Samkari2,3 1Department of Medicine, Massachusetts General Hospital, Boston, MA...
This thesis consists of studies aiming to answer questions regarding the pathophysiology (ie. the ro...
Immune thrombocytopenia (ITP) is a rare condition. Its epidemiology is not well-known. Fir...
La thrombopénie immunologique (TI) est une maladie auto-immune rare. Son épidémiologie est mal connu...
The natural history and its modulation by treatments administered for immune thrombocytopenia (ITP) ...
Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated ...
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated t...
The rarity of severe complications of this disease in children makes randomized clinical trials in i...
This thesis investigates immune-mediated thrombocytopenia: the natural history of immune thrombocyto...
5siIntroduction: Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a ...
Immune thrombocytopenia (ITP) is an acquired disorder characterized by isolated thrombocytopenia wit...
Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and ...
peer reviewedThe Belgian Hematology Society (BHS) updated the 2013 guidelines for diagnosis and trea...
peer reviewedThe Belgian Hematology Society (BHS) updated the 2013 guidelines for diagnosis and trea...
Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or t...
Fei Song,1,2 Hanny Al-Samkari2,3 1Department of Medicine, Massachusetts General Hospital, Boston, MA...
This thesis consists of studies aiming to answer questions regarding the pathophysiology (ie. the ro...